|
|
|
Volumn 98, Issue , 2006, Pages 257-271
|
|
Use of interferon-beta in the treatment of multiple sclerosis.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY;
BETA INTERFERON;
BIOLOGICAL RESPONSE MODIFIER;
CENTRAL NERVOUS SYSTEM;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFECT;
HUMAN;
IMMUNOLOGY;
MULTIPLE SCLEROSIS;
PATHOLOGY;
PATHOPHYSIOLOGY;
RECURRENT DISEASE;
REVIEW;
STATISTICS;
TREATMENT OUTCOME;
ANTIBODIES;
BIOLOGICAL RESPONSE MODIFIERS;
CENTRAL NERVOUS SYSTEM;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
INTERFERON-BETA;
MULTIPLE SCLEROSIS;
RECURRENCE;
TREATMENT OUTCOME;
|
|
EID: 33644843896
PISSN: 00913952
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (7)
|
|
References (33)
|
